Casasáh

FIGURE. Diagnosis and treatment in 284 consecutive patients with

Por um escritor misterioso
Last updated 03 abril 2025
FIGURE. Diagnosis and treatment in 284 consecutive patients with
FIGURE. Diagnosis and treatment in 284 consecutive patients with
Secondary Hyperparathyroidism in Non-dialysis Chronic Kidney
FIGURE. Diagnosis and treatment in 284 consecutive patients with
Diagnosis and management of diabetes insipidus for the internist
FIGURE. Diagnosis and treatment in 284 consecutive patients with
Influence of Prostate Artery Embolization on Different Qualities
FIGURE. Diagnosis and treatment in 284 consecutive patients with
Two Years into the COVID-19 Pandemic: Lessons Learned
FIGURE. Diagnosis and treatment in 284 consecutive patients with
Effect of Vasodilator Therapy on Mortality in Chronic Congestive
FIGURE. Diagnosis and treatment in 284 consecutive patients with
Clinical outcome of patients with a vitamin K antagonist
FIGURE. Diagnosis and treatment in 284 consecutive patients with
Estimating incidence of venous thromboembolism in COVID‐19
FIGURE. Diagnosis and treatment in 284 consecutive patients with
Diagnostic performance of sonographic activity scores for adult
FIGURE. Diagnosis and treatment in 284 consecutive patients with
Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of
FIGURE. Diagnosis and treatment in 284 consecutive patients with
High Interobserver Variability Among Pathologists Using Combined
FIGURE. Diagnosis and treatment in 284 consecutive patients with
A systematic review of biomarkers among hospitalized patients with
FIGURE. Diagnosis and treatment in 284 consecutive patients with
Frontiers Demographic, Virological Characteristics and Prognosis
FIGURE. Diagnosis and treatment in 284 consecutive patients with
Myostatin in combination with creatine phosphokinase or albumin
FIGURE. Diagnosis and treatment in 284 consecutive patients with
The effect of neoadjuvant therapy on PD-L1 expression and CD8+
Recomendado para você
você pode gostar

© 2014-2025 praharacademy.in. All rights reserved.